Neurologist Beau Ances, MD, PhD, talks with his patient, Adam Kloppenberg, who has Down syndrome, at Washington University School of Medicine in St. Louis. People with Down syndrome are at very high risk of developing Alzheimer’s disease. Ances is involved in a project led by Jason Hassenstab, PhD, an associate professor of neurology, to develop tools to measure cognitive function in people with Down syndrome-associated Alzheimer’s disease.
Kura aims for FDA approval with positive pivotal data for tipifarnib – Pharmaceutical Technology
Tipifarnib is a farnesyl transferase inhibitor (FTI), which is involved in cancer initiation and development. Image Credit: Kateryna Kon / Shutterstock. Kura Oncology announced positive
October 18, 2023